CVS Caremark has removed several therapies to treat patients with diabetes in favor of newer products and generics, and is ...

Abbott modified its original FreeStyle Libre 2 for the purpose of integration with automated insulin delivery systems. It ...

ACTON, Mass., November 20, 2024--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of ...

CEO Dev Kurdikar said the decision may “come as a surprise” as Embecta just received FDA clearance for a patch pump, but the company “did not intend to do a full market launch of this product.” ...

Insulet Corp. (PODD), a provider of tubeless insulin pump technology, announced Wednesday that the Omnipod 5 Automated Insulin ...

Embecta announced today that it discontinued its insulin patch pump program and plans to initiate a restructuring plan.

"We are excited to announce that Omnipod 5, the only AID system indicated for both type 1 and type 2 diabetes, is now integrated with Abbott's FreeStyle Libre 2 Plus sensor in the U.S. This latest ...

The insulin pump market is projected to reach $14bn in the same period, as per GlobalData analysis. Insulet also secured ...

Insulet Corp. PODD announced that its Omnipod ... adjusting insulin delivery every five minutes using its advanced SmartAdjust technology. As the most prescribed and preferred pump in the United ...